Published in Aliment Pharmacol Ther on December 01, 2003
Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal Disease | NCT00172809
Novel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patients. J Clin Microbiol (2005) 1.04
Superior outcomes in HIV-positive kidney transplant patients compared with HCV-infected or HIV/HCV-coinfected recipients. Kidney Int (2015) 1.04
Management of patients with hepatitis C infection and renal disease. World J Hepatol (2015) 0.95
Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis. J Gastroenterol (2016) 0.90
Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India. J Clin Exp Hepatol (2014) 0.90
Pegylated-interferon alpha 2a treatment for chronic hepatitis C in patients on chronic haemodialysis. World J Gastroenterol (2006) 0.86
Interferon for hepatitis C virus in hemodialysis--an individual patient meta-analysis of factors associated with sustained virological response. Clin J Am Soc Nephrol (2009) 0.85
Hepatitis C virus infection and dialysis: 2012 update. ISRN Nephrol (2012) 0.85
Managing chronic hepatitis C in the difficult-to-treat patient. Liver Int (2007) 0.84
Pegylated interferon-alpha 2b monotherapy for haemodialysis patients with chronic hepatitis C. Aliment Pharmacol Ther (2004) 0.81
Efficacy and safety of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C. World J Gastroenterol (2008) 0.81
A Better Quality of Life in Hemodialysis Patients With Viral Hepatitis: Is it a Reality? Hepat Mon (2013) 0.81
Efficacy and tolerability of low-dose interferon-α in hemodialysis patients with chronic hepatitis C virus infection. World J Gastroenterol (2014) 0.80
Hepatitis C in hemodialysis patients. World J Hepatol (2015) 0.80
Treatment of hepatitis C in hemodialysis patients using pegylated interferon alpha-2a in Turkey. J Gastroenterol (2009) 0.79
Management of hepatitis C virus infection in hemodialysis patients. World J Hepatol (2014) 0.79
Management of hepatitis C in patients with chronic kidney disease. World J Gastroenterol (2015) 0.78
Hepatitis C and kidney transplantation. Int J Nephrol (2011) 0.77
Management of the kidney transplant patient with chronic hepatitis C infection. Int J Nephrol (2011) 0.76
Lack of Efficacy of Pegylated Interferon Monotherapy for Hepatitis C in Patients With End-Stage Renal Disease on Dialysis. Gastroenterol Hepatol (N Y) (2006) 0.75
Hepatitis C Virus Infection in Patients with End-Stage Renal Disease: A Study from a Tertiary Care Centre in India. J Clin Exp Hepatol (2015) 0.75
Recurrent hepatitis C post-transplantation: where are we now and where do we go from here? A report from the Canadian transplant hepatology workshop. Can J Gastroenterol (2006) 0.75
Incidence of CMV-HCV coinfection in renal transplant recipient. BMJ Case Rep (2012) 0.75
1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant (1995) 24.01
Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol (1986) 10.84
Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem (1998) 8.30
The repair of double-strand breaks in the nuclear DNA of Saccharomyces cerevisiae and its genetic control. Mol Gen Genet (1976) 6.89
Nucleotide sequence of the tetM tetracycline resistance determinant of the streptococcal conjugative shuttle transposon Tn1545. Nucleic Acids Res (1986) 4.47
HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression. Science (1982) 4.07
Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem (1998) 3.78
Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med (1989) 3.45
Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry (1995) 3.30
An association between viral genes and human oncogenic alterations: the adenovirus E1A induces the Ewing tumor fusion transcript EWS-FLI1. Nat Med (1999) 3.27
Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway. Mol Cell (2001) 3.05
Dynamic actin-based epithelial adhesion and cell matching during Drosophila dorsal closure. Curr Biol (2000) 2.78
X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol (2000) 2.71
Mechanisms of epithelial fusion and repair. Nat Cell Biol (2001) 2.63
Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization. Differentiation (1997) 2.58
Failure of silicone gel breast implants: analysis of literature data for 1652 explanted prostheses. Plast Reconstr Surg (1997) 2.56
Nucleotide sequence of the human c-myc locus: provocative open reading frame within the first exon. EMBO J (1984) 2.55
Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med (1989) 2.42
Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C: results from a US database of over 45 000 HCV-infected, evaluated patients. Aliment Pharmacol Ther (2013) 2.38
Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature (1995) 2.33
Safeguards for research using large scale DNA collections. BMJ (2000) 2.22
env sequences of simian immunodeficiency viruses from chimpanzees in Cameroon are strongly related to those of human immunodeficiency virus group N from the same geographic area. J Virol (2000) 2.17
Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg (1997) 2.16
An immunohistochemical method that differentiates Cryptococcus neoformans varieties and serotypes in formalin-fixed paraffin-embedded tissues. Med Mycol (2001) 2.16
Meta-analysis of observational studies: hepatitis C and survival after renal transplant. J Viral Hepat (2013) 2.15
Putting ion channels to work: mechanoelectrical transduction, adaptation, and amplification by hair cells. Proc Natl Acad Sci U S A (2000) 2.15
Sequencing the erbA gene of avian erythroblastosis virus reveals a new type of oncogene. Science (1984) 2.12
Healing of incisional wounds in the embryonic chick wing bud: characterization of the actin purse-string and demonstration of a requirement for Rho activation. J Cell Biol (1996) 2.12
Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients. Am J Transplant (2011) 2.10
Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood (2001) 2.04
Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma. Ann Surg (1995) 2.03
[Hypodontia due to ectodermal dysplasia: rehabilitation with very early dental implants]. Rev Stomatol Chir Maxillofac Chir Orale (2013) 1.97
Hypodontia due to ectodermal dysplasia: rehabilitation with very early dental implants. Rev Stomatol Chir Maxillofac Chir Orale (2013) 1.97
Impaired wound healing in embryonic and adult mice lacking vimentin. J Cell Sci (2000) 1.92
Long-term survival after retransplantation of the liver. Ann Surg (1997) 1.91
Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Am J Gastroenterol (1997) 1.91
Proteolytic activation of the cell death protease Yama/CPP32 by granzyme B. Proc Natl Acad Sci U S A (1996) 1.90
A retrospective analysis of immunosuppression compliance, dose reduction and discontinuation in kidney transplant recipients. Am J Transplant (2007) 1.88
Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c. J Biol Chem (1998) 1.86
Identification of grandchildless loci whose products are required for normal germ-line development in the nematode Caenorhabditis elegans. Genetics (1991) 1.81
Comorbidity assessment in hemodialysis and peritoneal dialysis using the index of coexistent disease. Semin Dial (2001) 1.79
Associations of pretransplant serum albumin with post-transplant outcomes in kidney transplant recipients. Am J Transplant (2011) 1.79
Transforming viruses directly reduce the cellular growth requirement for a platelet derived growth factor. J Cell Physiol (1978) 1.79
Validation of a model of colon cancer progression. J Pathol (2000) 1.76
Macrophage recruitment during limb development and wound healing in the embryonic and foetal mouse. J Cell Sci (1994) 1.74
99mTc-tagged chicken liver as a marker of solid food in the human stomach. Am J Dig Dis (1976) 1.74
MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms. Oncogene (2012) 1.73
Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension. J Hypertens (1996) 1.73
Role of sympathectomy for hyperhidrosis. Br Med J (1971) 1.68
Localized two-dimensional shift correlated MR spectroscopy of human brain. Magn Reson Med (2001) 1.67
Evaluation of a novel serotyping system for hepatitis C virus: strong correlation with standard genotyping methodologies. J Clin Microbiol (1995) 1.65
Correlation between donor age and the pattern of liver graft recovery after transplantation. Transplantation (1995) 1.63
Sinonasal and sino-orbital aspergillosis in 23 cats: aetiology, clinicopathological features and treatment outcomes. Vet J (2011) 1.63
General practice patients on long-term psychotropic drugs. A controlled investigation. Br J Psychiatry (1988) 1.62
Ocular toxicity from ethambutol: a review of four cases and recommended precautions. N Z Med J (1998) 1.57
Development and evaluation of the Liver Disease Quality of Life instrument in persons with advanced, chronic liver disease--the LDQOL 1.0. Am J Gastroenterol (2000) 1.53
Development and practice of an autonomous minor surgery unit in a general hospital. Br Med J (1971) 1.53
Meta-analysis: levamisole improves the immune response to hepatitis B vaccine in dialysis patients. Aliment Pharmacol Ther (2010) 1.51
Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology (1998) 1.48
Opioid substitution to reduce adverse effects in cancer pain management. Med J Aust (1999) 1.48
Hepatitis C screening strategies in hemodialysis patients. Am J Kidney Dis (2001) 1.48
On the surgery of atherosclerosis of the profunda femoris artery. Surgery (1972) 1.48
Detection and identification of mycobacteria in fixed stained smears and formalin-fixed paraffin-embedded tissues using PCR. J Small Anim Pract (2013) 1.47
Retracted The remarkable cochlear amplifier. Hear Res (2010) 1.47
Leu-1+ (CD5+) B cells. A major lymphoid subpopulation in human fetal spleen: phenotypic and functional studies. J Immunol (1986) 1.46
Magnesium bioavailability from mineral water. A study in adult men. Eur J Clin Nutr (2002) 1.46
Location and type of mutation in the LIS1 gene do not predict phenotypic severity. Neurology (2007) 1.45
Studies of l(3)c43hs1 a polyphasic, temperature-sensitive mutant of Drosophila melanogaster with a variety of imaginal disc defects. Dev Biol (1977) 1.43
Kinetics of hepatitis B virus load and haemodialysis: a prospective study. J Viral Hepat (2008) 1.42
The Georgia Centenarian Study. Int J Aging Hum Dev (1992) 1.41
Influence of heparin thromboprophylaxis on plasma leucocyte elastase levels following lobectomy for lung carcinoma. Blood Coagul Fibrinolysis (1995) 1.41
Factors associated with severe intracranial hypertension in candidates for emergency liver transplantation. Transplantation (1993) 1.40
Arginine-rich peptides destabilize the plasma membrane, consistent with a pore formation translocation mechanism of cell-penetrating peptides. Biophys J (2009) 1.40
A cocoon of freshly accelerated cosmic rays detected by Fermi in the Cygnus superbubble. Science (2011) 1.39
Mutation spectrum in the nephrin gene (NPHS1) in congenital nephrotic syndrome. Hum Mutat (2001) 1.38
The cellular oncogenes c-myc, c-myb and c-erb are transcribed in defined types of avian hematopoietic cells. Exp Cell Res (1983) 1.38
Suspected toxicity of atracurium in the neonate. Paediatr Anaesth (2001) 1.38
Sensitivity of bioelectrical impedance to detect changes in human body composition. J Appl Physiol (1985) (1989) 1.38
The effectiveness of a cardiopulmonary resuscitation program for mothers of newborn infants. J Perinatol (1989) 1.38
Arteriosclerosis, amputation and peptic ulcer. Postgrad Med J (1972) 1.38
Evaluation of out-patient counselling compared with general practitioner care following overdoses. Psychol Med (1987) 1.37
Patient reports of complications of bone marrow transplantation. Support Care Cancer (2000) 1.36
ARX mutations in X-linked lissencephaly with abnormal genitalia. Neurology (2003) 1.36
Meta-analysis: the effect of age on immunological response to hepatitis B vaccine in end-stage renal disease. Aliment Pharmacol Ther (2004) 1.33
Characterization of quail Pax-6 (Pax-QNR) proteins expressed in the neuroretina. Mol Cell Biol (1993) 1.33
Injuries to restrained occupants in far-side crashes. Annu Proc Assoc Adv Automot Med (2000) 1.33
Induction of proliferation or transformation of neuroretina cells by the mil and myc viral oncogenes. Nature (1985) 1.32
Gastric emptying of solid food in normal man and after subtotal gastrectomy and truncal vagotomy with pyloroplasty. Gastroenterology (1977) 1.31
Transgenic expression of PML/RARalpha impairs myelopoiesis. Proc Natl Acad Sci U S A (1996) 1.31
Interaction of Maf transcription factors with Pax-6 results in synergistic activation of the glucagon promoter. J Biol Chem (2001) 1.30
The failure of compression stockings (Tubigrip) to prevent deep venous thrombosis after operation. Br J Surg (1970) 1.30
A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B. Hepatology (2001) 1.29
A model of loneliness in older adults. J Gerontol B Psychol Sci Soc Sci (1999) 1.29
Mesenchymal cells engulf and clear apoptotic footplate cells in macrophageless PU.1 null mouse embryos. Development (2000) 1.28